 BURLINGTON, Mass.--BUSINESS WIRE--- BBLG BoneBiologics--Bone Biologics Corp. NASDAQ: BBLG Bone Biologics or the Company, a developer of orthobiologic products for spine fusion markets, today announced that it closed a public offering of 1,510,455 units of securities at an offering price of 5.25 per unit, for total gross proceeds of 7.9 million, before deducting underwriting discounts and commissions and other estimated offering expenses. Each unit consists of one share of common stock and one warrant to 